See also this year's filing and all EDGAR filings for this company.
PDF Report 0001479290_2020_Revance_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001479290, Revance Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 296,602,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 14,755,000 |
| 3 | remainder_Assets | 28,930,000 |
| 4 | LiabilitiesCurrent | 40,979,000 |
| 5 | LiabilitiesNoncurrent | 73,818,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 72,792,290 |
| 9 | ResearchAndDevelopmentExpense | 111,475,563 |
| 10 | remainder_Expenses | 1,548,751 |
| 11 | remainder_Revenues | 3,342,890 |
| 12 | remainder_NetIncome | 5,380,848 |
| 13 | remainder_ComprehensiveNetIncome | 5,447 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 340,287,000 |
| 1 | Liabilities | 114,797,000 |
| 2 | Expenses | 185,816,604 |
| 3 | Revenues | 3,342,890 |
| 4 | StockholdersEquity | 225,490,000 |
| 5 | NetIncome | -177,092,866 |
| 6 | ComprehensiveNetIncome | -177,090,142 |
| 7 | BaseVar | 324,814,894 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.38 |
| 9 | EconomicCapitalRatio | 2.59 |
Edgar->Model Mapping
Feature Distribution
Change over Time
